PEPTONIC medical AB (publ) (FRA:28L)

Germany flag Germany · Delayed Price · Currency is EUR
0.0002
0.00 (0.00%)
At close: Dec 4, 2025
0.00%
Market Cap 8.20M
Revenue (ttm) 1.42M
Net Income (ttm) -4.43M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0002 - 0.0002
Beta n/a
RSI 39.38
Earnings Date Feb 22, 2026

About PEPTONIC medical AB

PEPTONIC medical AB (publ), a pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health. It offers VagiVital, a hormone-free treatment for symptoms related to vaginal atrophy, such as pain during intercourse, burning, itching, and dryness, as well as moisturizing and an oil-based intimate wash. The company also provides lifestyle consumer products under the Lunette brand. PEPTONIC medical AB (publ) was incorporated in 2009 and is headquartered in Bromma, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Employees 27
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 28L
Full Company Profile

Financial Performance

In 2024, PEPTONIC medical AB's revenue was 26.89 million, a decrease of -27.55% compared to the previous year's 37.12 million. Losses were -60.03 million, 40.9% more than in 2023.

Financial numbers in SEK Financial Statements

News

There is no news available yet.